Drug Target Review2026-01-05T10:16:00
Researchers in China have discovered a previously unknown mechanism that allows aggressive breast cancers to avoid immune attack, while simultaneously exposing a weakness that could make these tumours especially responsive to existing immunotherapy treatments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-07-04T10:05:58
Sponsored by Revvity
2023-03-07T10:55:58
Sponsored by Agilent
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
2024-01-19T07:40:55
Sponsored by Euretos
2026-07-21T09:36:00
Contributor Jayson Uffens, Drug Target Review
Site powered by Webvision Cloud